Han Ju

598 total citations
17 papers, 403 citations indexed

About

Han Ju is a scholar working on Epidemiology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Han Ju has authored 17 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 5 papers in Organic Chemistry and 5 papers in Molecular Biology. Recurrent topics in Han Ju's work include Influenza Virus Research Studies (13 papers), interferon and immune responses (3 papers) and Respiratory viral infections research (3 papers). Han Ju is often cited by papers focused on Influenza Virus Research Studies (13 papers), interferon and immune responses (3 papers) and Respiratory viral infections research (3 papers). Han Ju collaborates with scholars based in China, Italy and United States. Han Ju's co-authors include Xinyong Liu, Peng Zhan, Siyu Xiu, Bing Huang, Simon Cocklin, Alexej Dick, Sako Mirzaie, Fatemeh Abdi, Dongwei Kang and Ruifang Jia and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Han Ju

15 papers receiving 400 citations

Peers

Han Ju

EPIDE

CTM

Tianhong Zhang China

Long V. Pham Denmark

Nai-Wan Hsiao Taiwan

Jean Ndjomou United States

G.J. Lockbaum United States

Daniel Brian Nichols United States

Dongrong Yi China

Prasad Burra India

Soo Young Byun South Korea

N. Maltseva United States

Tianhong Zhang China

Han Ju

80 ×0.5

EPIDE

159 ×1.1

174 ×1.2

62 ×0.7

49 ×0.6

CTM

Citations per year, relative to Han Ju Han Ju (= 1×) peers Tianhong Zhang

Countries citing papers authored by Han Ju

Since Specialization

Citations

This map shows the geographic impact of Han Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Ju more than expected).

Fields of papers citing papers by Han Ju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Ju. The network helps show where Han Ju may publish in the future.

Co-authorship network of co-authors of Han Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Han Ju. A scholar is included among the top collaborators of Han Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Ju. Han Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wang, Jiacheng, Raymond Liang, Lu Zhang, et al.. (2025). Development of cell-permeable and plasma-stable peptidomimetic inhibitors against PSD-95/nNOS interaction as potential anti-ischemic stroke agents. European Journal of Medicinal Chemistry. 299. 118062–118062.

Zhang, Jiwei, Han Ju, Oriana Tabarrini, et al.. (2024). Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo. Antiviral Research. 230. 105980–105980. 3 indexed citations

Cao, Yuhao, et al.. (2024). The Implementation of Green Supply Chain Management. 1 indexed citations

Liu, Chuanfeng, Ying Zhang, Ping Li, et al.. (2023). Development of chalcone-like derivatives and their biological and mechanistic investigations as novel influenza nuclear export inhibitors. European Journal of Medicinal Chemistry. 261. 115845–115845. 3 indexed citations

Li, Ping, Han Ju, Ying Zhang, et al.. (2023). Discovery of ligustrazine and chalcone derivatives as novel viral nucleoprotein nuclear export inhibitors against influenza viruses. Journal of Medical Virology. 95(7). e28968–e28968. 10 indexed citations

Li, Ping, Han Ju, Fabao Zhao, et al.. (2023). Identification of the Imidazo[1,2-a]pyrazine Derivative A4 as a Potential Influenza Virus Nucleoprotein Inhibitor. ACS Pharmacology & Translational Science. 6(12). 1841–1850. 1 indexed citations

Jia, Ruifang, Jiwei Zhang, Jian Zhang, et al.. (2022). Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant. Molecules. 27(19). 6426–6426. 12 indexed citations

Ju, Han, Fabao Zhao, Ying Zhang, et al.. (2022). Iterative Optimization and Structure–Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity. Journal of Medicinal Chemistry. 65(17). 11550–11573. 12 indexed citations

Zhang, Ying, Han Ju, Srinivasulu Cherukupalli, et al.. (2021). Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins. Acta Pharmaceutica Sinica B. 12(4). 1805–1824. 21 indexed citations

10.

Ju, Han, N. Arul Murugan, Ping Li, et al.. (2021). Identification of C5-NH₂ Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability. Journal of Medicinal Chemistry. 64(24). 17992–18009. 15 indexed citations

11.

Jia, Ruifang, Jian Zhang, Chiara Bertagnin, et al.. (2020). Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity. European Journal of Medicinal Chemistry. 212. 113097–113097. 21 indexed citations

12.

Xiu, Siyu, Alexej Dick, Han Ju, et al.. (2020). Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities. Journal of Medicinal Chemistry. 63(21). 12256–12274. 171 indexed citations

13.

Ju, Han, et al.. (2020). Research trend analysis for North Korea Education Research using keyword network analysis. Korean Association For Learner-Centered Curriculum And Instruction. 20(11). 185–213. 1 indexed citations

14.

Ju, Han, Siyu Xiu, Xiao Ding, et al.. (2019). Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity. European Journal of Medicinal Chemistry. 187. 111940–111940. 30 indexed citations

15.

Jia, Ruifang, Jian Zhang, Han Ju, et al.. (2019). Discovery of Novel anti-influenza Agents Via Contemporary Medicinal Chemistry Strategies (2014–2018 update). Future Medicinal Chemistry. 11(5). 375–378. 13 indexed citations

16.

Ju, Han, Jian Zhang, Zheng Y. X. Huang, et al.. (2018). Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors. European Journal of Medicinal Chemistry. 146. 220–231. 29 indexed citations

17.

Ju, Han, Jian Zhang, Boshi Huang, et al.. (2017). Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives. Journal of Medicinal Chemistry. 60(9). 3533–3551. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact